PYC Therapeutics (ASX:PYC) raised AU$9.3 million via the retail component of its entitlement offer, bringing the total funds raised to AU$100 million, according to a Tuesday filing with the Australian bourse.
On Feb. 17, the company said it is set to raise up to AU$146 million via a pro-rata accelerated non-renounceable entitlement offer on the basis of one new share for every four shares held.
The balance will be raised through an underwriting facility expected before April 7, the filing said.
Shares of the company fell almost 3% in recent Tuesday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.